Session date: 
Wednesday, October 7, 2015 - 7:00am to 8:15am
Location: 
Eye Institute
925 N. 87th St.
Lower Level Conference Room
Milwaukee, WI 53226
United States
  • 1.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.25 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

Presentation #1: 

Establishing the Irish Diabetic Retinopathy Screening and Treatment Program (RetinaScreen)

Description #1:

Cover the rationale for establishing a screening programme. The steps to developing a coherent screening programme. The clinical and economic argument along with the role of advocacy. The link between an effective screen and subsequent treatment referral. The steps to the development of quality and clinical standards and ensuring that they are applied.

Objectives #1: 

  1. Awareness of effectiveness of population screening to limit sight loss due to diabetic retinopathy
  2. Method to establish a national diabetic retinopathy screening and treatment programme IT and management needs 
  3. Application of evidence based quality and clinical standards to a population based screening and treatment programme.         

Presentation #2: 

MicroRNA Biomarkers in Age Related Macular Degeneration

Description #2:

Present a series of studies on the search, validation, in vitro analysis and pathway prediction of potential serum microRNA biomarkers as candidates to predict diagnosis and prognosis in AMD.

Objectives #2: 

  1. An overview of the clinical biomarkers  
  2. The techniques to search for candidate serum biomarkers in AMD  
  3. Application of DIANA lab-mirPath to predict a number of significant pathways in pathogenesis of AMD
 
Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.25 hours of participation for continuing education for allied health professionals
Target audience: 
  • Community eye care professionals
  • Full time faculty
  • Residents
  • Fellow ophthalmologists
  • Optometrists
  • Ophthalmic photographers
Learning objectives: 

At the conclusion of this activity, I will be able to:

  1. Awareness of effectiveness of population screening to limit sight loss due to diabetic retinopathy
  2. Method to establish a national diabetic retinopathy screening and treatment programme IT and management needs 
  3. Application of evidence based quality and clinical standards to a population based screening and treatment programme.   
  4. An overview of the clinical biomarkers  
  5. The techniques to search for candidate serum biomarkers in AMD  
  6. Application of DIANA lab-mirPath to predict a number of significant pathways in pathogenesis of AMD
Faculty & credentials: 
Activity Directors:
Wanda M. Martinez, MD
Joe Carroll, PhD
 
Speaker:

David Keegan, PhD FRCOphth FRCSI(Oph)
Consultant Ophthalmic Surgeon
Mater Misericordiae University Hospital and Mater Private Hospital
Honorary Consultant Vitreo-retinal Surgeon
Temple Street Children's University Hospital

National Clinical Lead for Diabetic RetinaScreen Programme

 
All persons in control of content has no relevant financial relationships to disclose with the exception of the following persons;
 

Name

Company

Role

David Keegan, PhD, FRCOphth, FRCSI(Oph)

Novartis

Administrator

Bayer

Administrator

Diabetes Federation of Ireland

Speaker

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

CME Coordinator Contact Information

Name: 
Kelli Torosian
Phone number: 
+1 (414) 955-7875